Next step of molecular pathology: next-generation sequencing in cytology

키워드

참고문헌 (47)

1. Mosele F, "Recommendations for the use of next-generation sequencing(NGS)for patients with metastatic cancers : a report from the ESMO Precision Medicine Working Group", Ann Oncol, 31, pp.1491~1505 (2020)
2. Mosele MF, "Recommendations for the use of next-generation sequencing(NGS)for patients with advanced cancer in 2024 : a report from the ESMO Precision Medicine Working Group", Ann Oncol, 35, pp.588~606 (2021)
3. Stenzinger A, "Supporting biomarkerdriven therapies in oncology : a genomic testing cost calculator", Oncologist, 28, pp.e242~e253 (2023)
4. Danesi R, "Druggable targets meet oncogenic drivers : opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards", ESMO Open, 6, pp.100040~ (2021)
5. Pisapia P, "Next generation sequencing in cytology", Cytopathology, 32, pp.588~595 (2021)
6. Turner SA, "The basics of commonly used molecular techniques for diagnosis, and application of molecular testing in cytology", Diagn Cytopathol, 51, pp.83~94 (2023)
7. Roy-Chowdhuri S, "Collection and handling of thoracic small biopsy and cytology specimens for ancillary studies : guideline from the College of American Pathologists in collaboration with the American College of Chest Physicians, Association for Molecular Pathology, American Society of Cytopathology, American Thoracic Society, Pulmonary Pathology Society, Papanicolaou Society of Cytopathology, Society of Interventional Radiology, and Society of Thoracic Radiology", Arch Pathol Lab Med, 144, pp.933~958 (2020)
8. Morii E, "Guidelines for handling of cytological specimens in cancer genomic medicine", Pathobiology, 90, pp.289~311 (2023)
9. Sura GH, "Molecular testing opportunities on cytology effusion specimens : the pre-analytic effects of various body fluid cytology preparation methods on RNA extraction quality and targeted sequencing", J Am Soc Cytopathol, 12, pp.10~19 (2023)
10. Hwang DH, "Next-generation sequencing of cytologic preparations : an analysis of quality metrics", Cancer Cytopathol, 125, pp.786~794 (2017)
11. Kim H, "Biomarker testing of cytology specimens in personalized medicine for lung cancer patients", J Pathol Transl Med, 56, pp.326~333 (2022)
12. Roy-Chowdhuri S, "Preanalytic variables in cytology : lessons learned from next-generation sequencing : the MD Anderson experience", Arch Pathol Lab Med, 140, pp.1191~1199 (2016)
13. Li MM, "Standards and guidelines for the interpretation and reporting of sequence variants in cancer : a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists", J Mol Diagn, 19, pp.4~23 (2017)
14. Souza da Silva R, "Tissue management in precision medicine : what the pathologist needs to know in the molecular era", Front Mol Biosci, 9, pp.983102~ (2022)
15. Roy-Chowdhuri S, "Factors affecting the success of next-generation sequencing in cytology specimens", Cancer Cytopathol, 123, pp.659~668 (2015)
16. Zannini G, "A critical issue in lung cancer cytology and small biopsies: DNA and RNA extraction from archival stained slides for biomarker detection through real time PCR and NGS: the experience in pathological anatomy unit", Diagnostics (Basel), 13, pp.1637~ (2023)
17. Malapelle U, "Consistency and reproducibility of next-generation sequencing and other multigene mutational assays : a worldwide ring trial study on quantitative cytological molecular reference specimens", Cancer Cytopathol, 125, pp.615~626 (2017)
18. Hofman P, "What is new in biomarker testing at diagnosis of advanced non-squamous non-small cell lung carcinoma? Implications for cytology and liquid biopsy", J Mol Pathol, 2, pp.147~172 (2021)
19. Hofman P, "Current challenges and practical aspects of molecular pathology for non-small cell lung cancers", Virchows Arch, 484, pp.233~246 (2024)
20. de Jager VD, "Future perspective for the application of predictive biomarker testing in advanced stage nonsmall cell lung cancer", Lancet Reg Health Eur, 38, pp.100839~ (2024)
21. Roh MH, "The utilization of cytologic and small biopsy samples for ancillary molecular testing", Mod Pathol, 32, pp.77~85 (2019)
22. Tempero MA, "Pancreatic adenocarcinoma, version 2. 2021, NCCN clinical practice guidelines in oncology", J Natl Compr Canc Netw, 19, pp.439~457 (2021)
23. Tempero MA, "Pancreatic adenocarcinoma, version 2. 2021, NCCN clinical practice guidelines in oncology", J Natl Compr Canc Netw, 19, pp.439~457 (2021)
24. Roy-Chowdhuri S, "Concurrent fine needle aspirations and core needle biopsies : a comparative study of substrates for next-generation sequencing in solid organ malignancies", Mod Pathol, 30, pp.499~508 (2017)
25. Singhi AD, "Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia", Gut, 67, pp.2131~2141 (2018)
26. Paniccia A, "Prospective, multi-institutional, real-time next-generation sequencing of pancreatic cyst fluid reveals diverse genomic alterations that improve the clinical management of pancreatic cysts", Gastroenterology, 164, pp.117~133 (2023)
27. Souza da Silva R, "Comprehensive genomic studies on the cell blocks of pancreatic cancer", Diagnostics (Basel), 14, pp.906~ (2024)
28. Redegalli M, "Proposal for a new pathologic prognostic index after neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma(PINC)", Ann Surg Oncol, 29, pp.3492~3502 (2022)
29. Huang Y, "Does the adoption of molecular testing cause decreased thyroidectomy rates in a national cohort? A quasiexperimental study of high- versus low-adoption states", Thyroid, 34, pp.388~398 (2024)
30. McMurtry V, "Molecular testing in fineneedle aspiration of thyroid nodules", Diagn Cytopathol, 51, pp.36~50 (2023)
31. Schmitt F, "Thyroid FNA cytology", pp.233~244 (2023), Springer Nature Singapore
32. Subbiah V, "Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600-mutant anaplastic thyroid cancer", J Clin Oncol, 36, pp.7~13 (2018)
33. Dupain C, "Fine-needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology : prospective comparative study of nextgeneration sequencing in cancer patients included in the SHIVA02trial", Mol Oncol, 15, pp.104~115 (2021)
34. Gornjec A, "Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1", 2 genes in patients with tubo-ovarian high grade serous carcinoma, 2019, pp.19, 296~
35. Nozaki T, "Molecular analysis of ascitic fluid cytology reflects genetic changes of malignancies of the ovary equivalent to surgically resected specimens", Cancer Cytopathol, 130, pp.640~649 (2022)
36. Malapelle U, "Reference standards for gene fusion molecular assays on cytological samples : an international validation study", J Clin Pathol, 76, pp.47~52 (2023)
37. Schmitt F, "Molecular testing on cytology for gene fusion detection", Front Med (Lausanne), 8, pp.643113~ (2021)
38. Wolff HB, "Cost-effectiveness of parallel versus sequential testing of genetic aberrations for stage IV non-small-cell lung cancer in the Netherlands", JCO Precis Oncol, 6, pp.e2200201~ (2022)
39. Jager L, "Supernatant fluid from endobronchial ultrasound-guided transbronchial needle aspiration for rapid next-generation sequencing", J Am Soc Cytopathol, 13, pp.340~345 (2024)
40. Pepe F, "Tumor mutational burden on cytological samples : a pilot study", Cancer Cytopathol, 129, pp.460~467 (2021)
41. Alborelli I, "Robust assessment of tumor mutational burden in cytological specimens from lung cancer patients", Lung Cancer, 149, pp.84~89 (2020)
42. Amemiya K, "Deep targeted sequencing of cytological tumor cells using whole genome amplification", Cancer Cytopathol, 131, pp.58~68 (2023)
43. Gosney JR, "Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer : expert consensus on the rationale and considerations for implementation", ESMO Open, 8, pp.101587~ (2023)
44. Pisapia P, "Next generation sequencing in cytopathology : focus on non-small cell lung cancer", Front Med (Lausanne), 8, pp.633923~ (2021)
45. Marmarelis ME, "Brief report : impact of reflex testing on tissue-based molecular genotyping in patients with advanced non-squamous non-small cell lung cancer", Clin Lung Cancer, 25, pp.262~265 (2024)
46. Souza da Silva R, "Minimally invasive, maximally effective : the power of precision cytoanalysis on effusion samples : a comprehensive exploration from traditional methods to innovative approaches", Surg Pathol Clin, 17, pp.453~481 (2024)
47. Durin L, "Liquid biopsy of non-plasma body fluids in non-small cell lung cancer: look closer to the tumor!", Cells, 9, pp.2486~ (2020)

관련 논문AI추천